Sterol metabolism disorders and neurodevelopment-an update

Developmental Disabilities Research Reviews

Volumn 17, Issue 3, 2013, Pages 197-210

  Kanungo, Shibani ^a   Soares, Neelkamal ^b   He, Miao ^c   Steiner, Robert D ^d,e  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e MARSHFIELD CLINIC   (United States)

Author keywords

Cholesterol biosynthesis; Neurodevelopment; Sterol metabolism disorders

Indexed keywords

7 DEHYDROCHOLESTEROL; ANTIOXIDANT; ASCORBIC ACID; CANAKINUMAB; DESMOSTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STEROL; CHOLESTEROL; OXIDOREDUCTASE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTLEY BIXLER SYNDROME; CALCIFYING CHONDRODYSTROPHY; CK SYNDROME; CONGENITAL HEMIDYSPLASIA WITH ICTHYOSIFORM NEVUS AND LIMB DEFECT; DESMOSTEROLOSIS; DISORDERS OF LIPID METABOLISM; GENETIC COUNSELING; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; HYPOCHOLESTEROLEMIA; MEVALONIC ACIDURIA; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; RECURRENT FEVER; REVIEW; SMITH LEMLI OPITZ SYNDROME; STEROL C4 METHYL OXIDASE DEFICIENCY; STEROL METABOLISM; X LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA 2; ANIMAL; CHONDRODYSPLASIA PUNCTATA; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; DEFICIENCY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ENZYMOLOGY; INBORN ERROR OF STEROID METABOLISM; LIMB MALFORMATION; METABOLISM; MEVALONATE KINASE DEFICIENCY; MULTIPLE MALFORMATION SYNDROME; X CHROMOSOME LINKED DISORDER;

ABNORMALITIES, MULTIPLE; ANIMALS; CHOLESTEROL; CHONDRODYSPLASIA PUNCTATA; GENETIC DISEASES, X-LINKED; HUMANS; ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL; LIMB DEFORMITIES, CONGENITAL; LIPID METABOLISM, INBORN ERRORS; MEVALONATE KINASE DEFICIENCY; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; SMITH-LEMLI-OPITZ SYNDROME; STEROID METABOLISM, INBORN ERRORS; STEROLS;

EID: 84893351995     PISSN: 19405510     EISSN: 19405529     Source Type: Journal    
DOI: 10.1002/ddrr.1114     Document Type: Review

References (78)

1. Aneja A, Tierney E. 2008. Autism: the role of cholesterol in treatment. Int Rev Psychiatry 20:165-170
2. Bader-Meunier B, Florkin B, Sibilia J, et al. 2011. Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 128:e152-e158
3. Bianconi SE, Conley SK, Keil MF, et al. 2011. Adrenal function in Smith-Lemli-Opitz syndrome. Am J Med Genet Part A 155: 2732-2738
4. Bittar M, Happle R, Grzeschik KH, et al. 2006. CHILD syndrome in 3 generations: the importance of mild or minimal skin lesions. Arch Dermatol 142:348-351
5. Bjorkhem I, Meaney S. 2004. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24:806-815
6. Bodar EJ, Kuijk LM, Drenth JPH, et al. 2011. On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis 70:2155-2158
7. Bradley LA, Palomaki GE, Knight GJ, et al. 1999. Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses. Am J Med Gene 82:355-358
8. Brunetti-Pierri N, Corso G, Rossi M, et al. 2002. Lathosterolosis, a novel multiple-malformation/ mental retardation syndrome due to deficiency of 3beta-hydroxysteroiddelta5-desaturase. Am J Hum Genet 71:952-958
9. Bystron I, Blakemore C, Rakic P. 2008. Development of the human cerebral cortex: Boulder Committee revisited. Nat Rev Neurosci 9:110-122
10. Chaudhury S, Hormaza L, Mohammad S, et al. 2012. Liver transplantation followed by allogeneic hematopoietic stem cell transplantation for atypical mevalonic aciduria. Am J Transplant
11. Clee SM, Kastelein JJ, van Dam M, et al. 2000. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest 106:1263-1270
12. Cooper MK, Wassif CA, Krakowiak PA, et al. 2003. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet 33:508-513
13. Corcoran RB, Scott MP. 2006. Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc Natl Acad Sci USA 103:8408-8413
14. Correa-Cerro LS, Porter FD. 2005. 3betahydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome. Mol Genet Metab 84:112-126
15. Cuisset L, Drenth JP, Simon A, et al. 2001. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet 9:260-266
16. Dietschy JM, Turley SD. 2004. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45:1375-1397
17. Drenth JP, Van Der Meer JW. 2001. Hereditary periodic fever. N Engl J Med 345:1748- 1757
18. Engelhardt B, Sorokin L. 2009. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol 31:497-511
19. Fuccillo M, Joyner AL, Fishell G. 2006. Morphogen to mitogen: the multiple roles of hedgehog signalling in vertebrate neural development. Nat Rev Neurosci 7:772-783
20. Haas D, Hoffmann GF. 2006. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis 1:13
21. Happle R, Effendy I, Megahed M, et al. 1996. CHILD syndrome in a boy. Am J Med Genet 62:192-194
22. He M, Kratz LE, Michel JJ, et al. 2011. Mutations in the human SC4MOL gene encoding a methyl sterol oxidase cause psoriasiform dermatitis, microcephaly, and developmental delay. J Clin Invest 121:976-984
23. Herman GE. 2003. Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes. Hum Mol Genet 12:75-88
24. Houten SM, Frenkel J, Rijkers GT, et al. 2002. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet 11:3115-3124
25. Ikonen E. 2006. Mechanisms for cellular cholesterol transport: defects and human disease. Physiological Rev 6:1237-1261
26. Ingham PW, McMahon AP. 2001. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15:3059-3087
27. Irons M. Smith-Lemli-Opitz syndrome In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. GeneReviews TM [Internet]. Seattle (WA): University of Washington, Seattle; November 13, 1993-1998 [updated October 24, 2007]
28. Irons M, Elias ER, Salen G, et al. 1993. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet 341:1414
29. Irons MB, Nores J, Stewart TL, et al. 1999. Antenatal therapy of Smith-Lemli-Opitz syndrome. Fetal Diagn Ther 14:133-137
30. Jurevics HA, Kidwai FZ, Morell P. 1997. Sources of cholesterol during development of the rat fetus and fetal organs. J Lipid Res 38:723-733
31. Kalderon D. 2000. Transducing the Hedgehog Signal. Cell, Vol. 103, 371-374, October 27
32. Kelley RI. 1995. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin Chim Acta 236:45-58
33. Kelley RI, Hennekam RC. 2000. The Smith-Lemli-Opitz syndrome. J Med Genet 37:321-335
34. Kelley RI, Herman GE. 2001. Inborn errors of sterol biosynthesis. Annu Rev Genomics Hum Genet 2:299-341
35. Kelley RL, Roessler E, Hennekam RC, et al. 1996. Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog? Am J Med Genet 66:478-484
36. Kelley RI, Wilcox WG, Smith M, et al. 1999. Abnormal sterol metabolism in patients with Conradi-Hunermann-Happle syndrome and sporadic lethal chondrodysplasia punctata. Am J Med Genet 83:213-219
37. Krakowiak PA, Wassif CA, Kratz L, et al. 2003. Lathosterolosis: an inborn error of human and murine cholesterol synthesis due to lathosterol-5-desaturase deficiency. Hum Mol Genet 12:1631-1641
38. Kratz LE, Kelley RI. 1999. Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet 82:376-381
39. Linck LM, Lin DS, Flavell D, et al. 2000. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome. Am J Med Genet 93:360-365
40. Mandey SH, Schneiders MS, Koster J, et al. 2006. Mutational spectrum and genotype- phenotype correlations in mevalonate kinase deficiency. Hum Mutat 27: 796-802
41. Marti E, Bovolenta P. 2002. Sonic hedgehog in CNS development: one signal, multiple outputs. Trends Neurosci 25:89-96
42. McLarren KW, Severson TM, du Souich C, et al. 2010. Hypomorphic temperature-sensitive alleles of NSDHL cause CK syndrome. Am J Hum Genet 87:905-914
43. Neven B, Valayannopoulos V, Quartier P, et al. 2007. Allogeneic bone marrow transplantation in mevalonic aciduria. N Engl J Med 356:2700-2703
44. Nowaczyk MJ, Waye JS, Douketis JD. 2006. DHCR7 mutation carrier rates and prevalence of the RSH/Smith-Lemli-Opitz syndrome: where are the patients? Am J Med Genet A 140:2057-2062
45. Pfrieger FW. 2003. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? Bioessays 25:72-78.
46. Pitkin RM, Connor WE, Lin DS. 1972. Cholesterol metabolism and placental transfer in the pregnant Rhesus monkey. J Clin Invest 51:2584-2592
47. Plotz EJ, Kabara JJ, Davis ME, et al. 1968. Studies on the synthesis of cholesterol in the brain of the human fetus. Am J Obstet Gynecol 101:534-538
48. Porter FD, Herman GE. 2011. Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res 52:6-34
49. Porter JA, Young KE, Beachy PA. 1996. Cholesterol modification of hedgehog signaling proteins in animal development. Science 274:255-259
50. Reardon W, Smith A, Honour JW, et al. 2000. Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? J Med Genet 37:26-32
51. Redzic Z. 2011. Molecular biology of the bloodbrain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 8:3. doi: 10.1186/2045-8118-8-3
52. Roessler E, Belloni E, Gaudenz K, et al. 1996. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 14:357-360
53. Rossi M, D'Armiento M, Parisi I. 2007. Clinical phenotype of lathosterolosis. Am J Med Genet A 143:2371-2381
54. Ryan AK, Bartlett K, Clayton P, et al. 1998. Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet 35:558-565
55. Salway JG. 2004. Metabolism at a glance, 3rd ed. Blackwell Publishing: Oxford. p 72-73
56. Schaaf CP, Koster J, Katsonis P, et al. 2011. Desmosterolosis- phenotypic and molecular characterization of a third case and review of the literature. Am J Med Genet Part A 155:1597-1604
57. Shackleton CH, Marcos J, Palomaki GE, et al. 2007. Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS). Am J Med Genet A 143:2129- 2136
58. Sikora DM, Pettit-Kekel K, Penfield J, et al. 2006. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet A 140:1511-1518
59. Sikora DM, Ruggiero M, Petit-Kekel K, et al. 2004. Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome. J Pediatr 144:783-791
60. Simon A, Drewe E, van der Meer JW, et al. 2004. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476-483
61. Smith DW, Lemli L, Opitz JM. 1964. A newly recognized syndrome of multiple congenital anomalies. J. Pediatr 64:210-217
62. Stottmann RW, Turbe-Doan A, Tran P, et al. (2011) Cholesterol metabolism is required for intracellular hedgehog signal transduction in vivo. PLoS Genet 7:e1002224
63. Tarpey PS, Smith R, Pleasance E, et al. 2009. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet 41:535-543
64. Tierney E, Bukelis I, Thompson RE, et al. 2006. Abnormalities of cholesterol metabolism in autism spectrum disorders. Am J Med Gene 141:666-668
65. Tierney E, Nwokoro NA, Kelley RI. 2000. Behavioral phenotype of RSH/Smith-Lemli-Opitz syndrome. Ment Retard Dev Disabil Res Rev 6:131-134
66. Toplak N, Dolezalova P, Constantin T, et al. Eastern/ Central European autoinflammatory collaborating group for the Paediatric Rheumatology International Trials Organization (PRINTO) and Eurofever Project. Periodic fever syndromes in Eastern and Central European countries: results of a pediatricmultinational survey. Pediatr RheumatolOnline J. 2010 Dec 2;8:29
67. Van der Hilst JC, Bodar EJ, Barron KS, et al. 2008. Long-term follow up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Med (Baltimore) 87:301-310
68. Virgintino D, Errede M, Girolamo F, et al. 2008. Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development. J Neuropathol Exp Neurol 67:50-61
69. Virgintino D, Robertson R, Benagiano V, et al. 2000. Immunogold cytochemistry of the blood-brain barrier glucose transporter GLUT1 and endogenous albumin in the developing human brain. Dev Brain Res 123:95-101
70. Vockley J, Smith LD, Chang R, et al. SC4MOL Deficiency, A New Genetic Disorder in Cholesterologenesis. American College of Medical Genetics 2010 Annual Meeting, March 24-28, 2010 Albuquerque,New Mexico
71. Voet D, Voet JG. Biochemistry, 3rd ed. Wiley: 2004. p 942-959
72. Volpe JJ. Neuronal proliferation, migration, organization, and myelination. In: WB Saunders Company ed. Neurology of the Newborn. Philadelphia, PA: WB Saunders Company, A Division of Harcourt Brace & Company, 1995:43-92
73. Wassif CA, Krakowiak PA, Wright BS, et al. 2005. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts. Mol Genet Metab 85:96-107
74. Wassif CA, Maslen C, Kachilele-Linjewile S, et al. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet 1998;63:55-62
75. Waterham HR, Duran M. 2008 "Diagnosis of inherited defects of cholesterol biosynthesis". In: Blau N, Duran M, Gibson KM, editors. Laboratory guide to the methods in biochemical genetics. Springer-Verlag: Berlin Heidelberg. Chapter 5.1, p 484-497
76. Witsch-Baumgartner M, Gruber M, Kraft HG. 2004. Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. J Med Genet 41:577-584
77. Witsch-Baumgartner M, Schwentner I, Gruber M, et al. 2008. Age and origin of major Smith-Lemli-Opitz Syndrome (SLOS) mutations in European populations. J Med Genet 45:200-209
78. Zolotushko et al. 2011. The desmosterolosis phenotype: spasticity, microcephaly and micrognathia with agenesis of corpus callosum and loss of white matter. Eur J Hum Gene 19:942-946